Value sales of analgesics in New Zealand are increasing in 2025, with the local emphasis on self-care driving usage for mild to moderate pain and fever, inflammatory pain such as muscle aches and menstrual cramps, back pain, and colds and fever.
This report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2025, allowing you to identify the sectors driving growth. Forecasts to 2030 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
This report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2025, allowing you to identify the sectors driving growth. Forecasts to 2030 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN NEW ZEALANDDEFINITIONS
2025 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
